|
|
Article: Financings Roundup.
- Article from:
- BIOWORLD Today
- Article date:
- October 7, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Accumetrics Inc., of San Diego, completed a round of financing to raise $16.5 million from existing investors, including Arnerich Massena, BBT Fund/Apothecary Capital, Essex Woodlands Health Ventures, Kaiser Permanente Ventures and RiverVest Venture Partners. The capital will come in two transactions, with the first this year and the second next year. Funds will be used to complete a number of milestones planned for 2010, including expanded claims for existing products, new product development and continued expansion of commercialization efforts. Accumetrics develops the VerifyNow diagnostic system for measuring response to antiplatelet agents.
Adventrx ...
Related newspaper, magazine, and journal articles:
|
|
Article: COMPANY FORGING AHEAD WITH DIABETES DRUG AMYLIN STOCK DROPS 77 ...
BIOWORLD Today;
October 22, 1998 ;
700+ words
... ... price dropped below $8.50. (See BioWorld Today, Aug. 19, 1997, p. 1.) Along ... U.S. and Europe," Krawiec told BioWorld Today. Tanner said Amylin's move to continue ... J $36 million from a loan. (See BioWorld Today, March 3, 1998, p. 1.) Terms ...
|
|